Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I…

Overview of attention for article published in OncoImmunology, February 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 15 X users

patent: 1 patent

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 19 X posts from 15 X users, with an upper bound of 8,276 followers.

RT @scancellpharma: SCIB1 melanoma paper published in full... https://t.co/FX0FEGf6ty

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. https://t.co/5FQDIyfuyL

RT @scancellpharma: SCIB1 melanoma paper published in full... https://t.co/FX0FEGf6ty

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 15 additional X posts.